![Conley Chee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Conley Chee
Chief Executive Officer at SYROS PHARMACEUTICALS, INC.
Net worth: 114 770 $ as of 2024-05-30
Profile
Conley Chee is currently the President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. Prior to this, he worked at Novartis Pharmaceuticals as the Global Head-Portfolio Management from 2018 to 2021.
Mr. Chee completed his undergraduate degree at the University of Alberta and holds an MBA from the Richard Ivey School of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-04 | 22,504 ( 0.08% ) | 114 770 $ | 2024-05-30 |
Conley Chee active positions
Companies | Position | Start |
---|---|---|
SYROS PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-12-01 |
Former positions of Conley Chee
Companies | Position | End |
---|---|---|
Novartis Pharmaceuticals
![]() Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | 2021-02-27 |
Training of Conley Chee
Richard Ivey School of Business | Masters Business Admin |
University of Alberta | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SYROS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Pharmaceuticals
![]() Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
- Stock Market
- Insiders
- Conley Chee